Shorter DAPT Tested Following CABG - Scorecard - MDSpire

Shorter DAPT Tested Following CABG

TOP-CABG compared 3 months vs 12 months of ticagrelor plus aspirin following bypass surgery.

  • By

  • Kathryn Wighton

  • June 8, 2026

  • 6 min

Share

Clinical Scorecard: Shorter DAPT Tested Following CABG

At a Glance

CategoryDetail
Condition
Key MechanismsTicagrelor-based dual antiplatelet therapy (DAPT) for reducing SVG occlusion and bleeding risk.
Target Population
Care Setting

Key Highlights

  • Emphasize the clinical relevance of the noninferiority findings for SVG occlusion.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Monitor for SVG occlusion and bleeding events within 1 year, including specific imaging techniques.

      Risks

        Patient & Prescribing Data

        Detail patient selection criteria for the 3-month DAPT strategy.

        Clinical Best Practices

        • Include a note on excluding patients unable to tolerate early postoperative DAPT.

        Related Resources & Content

        Original Source(s)

        Shorter DAPT Tested Following CABG

        • by Kathryn Wighton

        • June 8, 2026

        Related Content

        AD Not Linked to Early CV Risk Markers

        Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

        Does Mitral Regurgitation Mechanism Matter After M-TEER?

        Left ventricular diameter changes were similar across subtypes at 1 month, while pulmonary artery systolic pressure responses differed by mechanism.

        Pilot Study Assesses AI-Guided Cardiac Ultrasound

        Researchers examined image acquisition, interpretation agreement, and clinical management decisions among advanced practice providers.